About this trial
Coughing affects almost all individuals with ILD leading to physical, psychological and social distress and prevents individuals from performing their activities of daily living, working or socialising in public places. Unfortunately, there are no licensed medications available to treat chronic cough and the few drugs that have been tried resulted in little efficacy and significant side effects. Drug-free cough control interventions have shown promise in reducing the severity and impact of coughing on patients' lives but have not been tested in individuals with ILD. This study aims to explore the feasibility and effectiveness of a non-pharmacological cough control therapy, as an adjuvant of pulmonary rehabilitation, in patients with ILD and chronic cough (\>8 weeks in duration).
Eligibility criteria
Qualifiers
Individuals will be included if having confirmed diagnosis of any ILD by a physician (as per Canadian Thoracic Society's guideline for evaluating patients with fibrotic interstitial lung disease) and a chronic cough lasting more than 8 weeks in duration
Disqualifiers
self-reports of moderate or large sputum production
effective or suspected exacerbation of the respiratory condition in the past month
upper respiratory tract infection in the past month
use of angiotensin-converting enzyme inhibitor medication
Trial design
Treatments tested in this trial
- Non-pharmacological Cough control Therapy
Treatment groups
Sponsors and collaborators
West Park Healthcare Centre
Lead sponsor
St. Joseph's Healthcare Hamilton
Collaborator